Positron emission tomography in patients with head and neck carcinoma

Journal Article · Sun Dec 31 00:00:00 EST 1995 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/0360-3016(95)97934-S· OSTI ID:471552

Jones, C U; Valk, P E; Johnson, E E; Pounds, T R

To examine the role of positron emission tomography (PET) with labeled flourodeoxyglucose (FDG) in patients with primary neoplasms of the head and neck. Between 9/92 and 9/94, forty-four FDG PET scans were performed on 27 patients with head and neck neoplasms. FDG uptake at the tumor sites was quantified with standardized uptake values (SUV).

• OSTI ID: 471552
• Report Number(s): CONF-9510337-; ISSN 0360-3016; TRN: 96:005695-0014
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Vol. 32, Issue Suppl.1; Conference: 37. therapeutic radiology and oncology annual meeting, Miami Beaach, FL (United States), 8-11 Oct 1995; Other Information: PBD: 1995
• Country of Publication: United States
• Language: English

Related Subjects

55 BIOLOGY AND MEDICINE
BASIC STUDIES
HEAD
CARCINOMAS
NECK
POSITRON COMPUTED TOMOGRAPHY
METASTASES
NEOPLASMS
FLUORODEOXYGLUCOSE
LABELLED COMPOUNDS